CI & Patents News: 2/12/2010

1) Para IV:

Ibandronate tablets: Hoffmann La Roche Vs Watson (View on PriorSmart)

Filed at District of New Jersey on Nov. 29, 2010

Method of treatment using bisphosphonic acid
by Bauss et. al.; USPC #514/108;
prosecuted by Johnston; George W. Rocha-Tramaloni; Patricia S. Wildman; David E.;
Diphosphonate derivatives, pharmaceutical compositions and methods of use
by Gall et. al.; USPC #514/108;
prosecuted by Felfe & Lynch;
Method of treatment using bisphosphonic acid
by Bauss et. al.; USPC #514/108;
prosecuted by Johnston; George W. Rocha-Tramaloni; Patricia S. Wildman; David E.;
Oral pharmaceutical preparation containing ibandronat
by Mockel et. al.; USPC #424/482;
prosecuted by Arent Fox Kintner Plotkin Kahn;

and 6,294,196; 7,192,938

2) Sorefenib Infringement case (Bayer Vs Cipla)

Judge framed the issues for trail without  hearing interim injunction application by Bayer and in addition to this, SC rejected SLP filed by Bayer on Patent linkage system and asked Delhi high court to decide this issue along with infringement case

…On Wednesday, the Supreme Court rejected the special leave petition filed by Bayer. “The court said this matter should be decided in its patent infringement suit which is pending with the Delhi HC,” said Prathibha Siva, who represented Cancer Patients Association of India, a party to the Bayer-Cipla case…. (Original link)

3) Glaxo close to buying Chinese drugmaker: sources (Live Mint)

4) Indian API exports to more than double by 2013-14 (Link)

5) India, China among fastest developing pharma destinations (link)

6) Merck to Acquire SmartCells, Inc (Press Release)

7) Pfizer May Release New Alzheimer Drug in 2-3 Years (Link)

8) Emami frontrunner to bag Paras Pharma for about Rs 3,000 cr (Link)

9) Galapagos candidate cachexia drug, GLPG0492, shows good safety and profile suitable for once-daily oral dosing (Press Release)

10) Abbott Laboratories along with partner Sucampo Pharmaceuticals Inc recently reported positive top-line data from a late-stage trial of lubiprostone in Japanese patients with chronic idiopathic constipation (CIC)

11) Daptomycin: Cubist Pharmaceuticals Receives FDA Approval for 2-Minute IV Injection of CUBICIN (Link)

12) India to become key player in biosimilars market by 2015: Experts (Pharma Biz)

13) Sunitinib: SUTENT® Receives European Approval for a New Indication in Progressive Pancreatic Neuroendocrine Tumors (NET) (Press Release)

14) Indian patent examinations hit due to ongoing battle (link)

15) Watson Launches ella® (ulipristal acetate) Emergency Contraceptive (Press Release) Watson is the exclusive marketer of ella(R) in the U.S. under terms of a distribution agreement announced earlier this year

16) Dabur enters the OTC healthcare segment (BS)

17) Google’s constructive initiative in Patent space: Google signs deal to translate European patents (Link)

Google announced an agreement Tuesday to use its technology to translate patents into 29 European languages, a deal officials hope will smooth the way toward a simplified European patent system after years of infighting. Note: Reecntly Google and the USPTO have entered into an agreement to make the USPTO products available to the public at no charge [Patents (grants, published applications, assignments, classification information, and maintenance fee events); Trademarks (registrations, applications, assignments, and TTAB proceedings)] Link for google USPTO’s data hosting page

18) EU trade commissioner assures solution for drug seizure issue (Live Mint)

19) Demand for changes in patent law rejected (ET) & Govt plans VC fund to promote new drug research (ET)

20) Strides arcolab announces US FDA approval of Midazolam HCl injection

About Guna

Interested to learn things around me
This entry was posted in Daily interesting IP news. Bookmark the permalink.

2 Responses to CI & Patents News: 2/12/2010

  1. sheetal says:

    Please let me know of the latest Patent news.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s